Michael Gruber

Michael Gruber

Auto-generated profile, based on publicly available information

Michael Gruber

University Clinic for Gynecology and Obstetrics, Medical University of Graz

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MGMichael M. Gruber
Michael M. Gruber
BHBirgit Hirschmugl
Birgit Hirschmugl
NBNatascha Berger
Natascha Berger
MHMagdalena Holter
Magdalena Holter
SRSnjezana Radulovic
Snjezana Radulovic
Christian WadsackChristian Wadsack
Christian Wadsack
Background: Nanoparticles, which are exposed to biological fluids are rapidly interacting with proteins and other biomolecules forming a corona. In addition to dimension, charge and material the distinct protein corona influences the interplay of nanoparticles with tissue barriers. In this study we were focused on the impact of in situ formed human plasma protein corona on the transfer of 80 nm polystyrene nanoparticles (PS-particles) across the human placenta. To study materno-to fetal PS transfer we used the human ex vivo placental perfusion approach, which represents an intact and physiological tissue barrier. To analyze the protein corona of PS particles we performed shotgun proteomics of isolated nanoparticles before and after tissue exposure. Results: Human plasma incubated with PS-particles of 80 nm and subsequent formed protein corona enhanced the transfer across the human placenta compared to PS-corona formed by bovine serum albumin and dextran which served as a control. Quantitative and qualitative changes of plasma proteins determined the changes in PS transfer across the barrier. Based on the analysis of the PS-proteome two candidate proteins, namely human albumin and immunoglobulin G were tested if these proteins may account for the enhanced PS-transfer across the placenta. Interestingly, the protein corona formed by human albumin significantly induced the transfer of PS-particles across the tissue compared to the formed IgG-corona. Conclusion: In total we demonstrate the PS corona dynamically and significantly evolves upon crossing the human placenta. Thus, the initial composition of PS particles in the maternal circulation is not predictive for their transfer characteristics and performance once beyond the barrier of the placenta. The precise mechanism of these effects remains to be elucidated but highlights the importance of using well designed biological models when testing nanoparticles for biomedical applications.

1 January 2021 in Placenta
Verified
Journal Article
Open access
LALeonie Aengenheister
Leonie Aengenheister
RFRodolfo Favaro
Rodolfo Favaro
DMDiana M. Morales-Prieto
Diana M. Morales-Prieto
LFLea A. Furer
Lea A. Furer
MGMichael Gruber
Michael Gruber
TBTina Buerki-Thurnherr
Tina Buerki-Thurnherr
Increasing human exposure to nanoparticles (NPs) from various sources raises concerns for public health, especially for vulnerable risk groups like pregnant women and their developing fetuses. However, nanomedicine and the prospect of creating safe and effective NP-based formulations of drugs hold great promise to revolutionize treatment during pregnancy. With maternal and fetal health at stake, risks and opportunities of NPs in pregnancy need to be carefully investigated. Importantly, a comprehensive understanding of NP transport and effects at the placenta is urgently needed considering the central position of the placenta at the maternal-fetal interface and its many essential functions to enable successful pregnancy. The perfusion of human placental tissue provides a great opportunity to achieve predictive human relevant insights, circumventing uncertainties due to considerable differences in placental structure and function across species. Here, we have reviewed the current literature on the ex vivo human placenta perfusion of NPs. From 16 available studies, it was evident that placental uptake and transfer of NPs are highly dependent on their characteristics like size and surface modifications, which is in line with previous observations from in vitro and animal transport studies. These studies further revealed that special considerations apply for the perfusion of NPs and we identified relevant controls that should be implemented in future perfusion studies. While current studies mostly focused on placental transfer of NPs to conclude on potential fetal exposure, the ex vivo placental perfusion model has considerable potential to reveal novel insights on NP effects on placental tissue functionality and signaling that could indirectly affect maternal-fetal health.

24 June 2021 in Histochemistry and Cell Biology
Verified
Journal Article
Open access
PDF file
MGMichael Gruber
Michael Gruber
EWElisa Weiß
Elisa Weiß
MSMonika Siwetz
Monika Siwetz
UHUrsula Hiden
Ursula Hiden
Martin GausterMartin Gauster
Martin Gauster
Human umbilical vein and artery endothelial cells (HUVEC; HUAEC), placental endothelial cells (fpAEC), and endothelial colony-forming cells (ECFC) from cord blood are a widely used model for researching placental vascular development, fetal and placental endothelial function, and the effect of adverse conditions in pregnancy thereon. However, placental vascular development and angiogenesis start in the first weeks of gestation, and adverse conditions in pregnancy may also affect endothelial function before term, suggesting that endothelial cells from early pregnancy may respond differently. Thus, we established a novel, gentle flow-through method to isolate pure human umbilical endothelial cells from first trimester (FTUEC). FTUEC were characterized and their phenotype was compared to the umbilical endothelium in situ as well as to other fetal endothelial cell models from term of gestation, i.e. HUVEC, fpAEC, ECFC. FTUEC possess a CD34-positive, juvenile endothelial phenotype, and can be expanded and passaged. We regard FTUEC as a valuable tool to study developmental processes as well as the effect of adverse insults in pregnancy in vitro.

28 February 2023
Verified
Book Chapter
Closed access
PDF file
MGMichael Gruber
Michael Gruber
BHBirgit Hirschmugl
Birgit Hirschmugl
CSCarolin Schliefsteiner
Carolin Schliefsteiner
Christian WadsackChristian Wadsack
Christian Wadsack

19 April 2018
Verified
Book Chapter
Closed access
PDF file
MGMichael Gruber
Michael Gruber
BHBirgit Hirschmugl
Birgit Hirschmugl
CSCarolin Schliefsteiner
Carolin Schliefsteiner
CWChristian Wadsack
Christian Wadsack

28 February 2023
Verified
Book Chapter
Closed access
PDF file
Martin GausterMartin Gauster
Martin Gauster
MGMichael Gruber
Michael Gruber
BHBirgit Hirschmugl
Birgit Hirschmugl
CSCarolin Schliefsteiner
Carolin Schliefsteiner
Christian WadsackChristian Wadsack
Christian Wadsack